whether or not the HRC price at that time was significantly increase or decrease. Management’s Discussion and Analysis (MD&A) For Q3/2017 5 Executive Summary In the third quarter of 2017, the company has
| 2 Executive Summary In 3Q/2019, overall palm oil production and crude palm oil (CPO) inventory remained high in both domestic and international market, thus crude palm oil (CPO) and crude palm kernel
shareholders and directors of Modern Pharma Company Limited are not Executive Committee and shareholders including those with controlling power in the company. Therefore, it is not considered a connected
informed accordingly. Yours sincerely, U City Public Company Limited _______________________________ (Ms. Piyaporn Phanachet) Chief Executive Officer Enclosure 1 1 (-Translation-) INFORMATION MEMORANDUM ON
property management fee at the rate of not exceeding 3.00 percent of WHART Trust’s net asset value - 3 - 5. Authority Given to Chief Executive Officer or Person Assigned by Chief Executive Officer in
the cost of production is manageable while we can improve the selling price. 2. Business Outlook on Q3/2017 Management’s Discussion and Analysis (MD&A) For Q2/2017 3 Executive Summary In the second
Discussion and Analysis (MD&A) for year 2017 3 Executive Summary In overall 2017 performance, the Company had significant improvements in various areas such as production increase to 875,874 tons, sale volume
on Q1/2018 Management’s Discussion and Analysis (MD&A) for year 2017 (Revised) 3 Executive Summary In overall 2017 performance, the Company had significant improvements in various areas such as
the slowdown of the market. Hence, there Q1/19 production will be low comparing to other quarter. Executive Summary The company's operating results in the year 2018 has significantly increased both